CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 36 filers reported holding CLEARSIDE BIOMEDICAL INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $4,000 | -33.3% | 4,164 | 0.0% | 0.00% | – |
| Q1 2019 | $6,000 | +50.0% | 4,164 | 0.0% | 0.00% | – |
| Q4 2018 | $4,000 | -84.6% | 4,164 | 0.0% | 0.00% | – |
| Q3 2018 | $26,000 | -42.2% | 4,164 | 0.0% | 0.00% | – |
| Q2 2018 | $45,000 | +12.5% | 4,164 | +11.5% | 0.00% | – |
| Q1 2018 | $40,000 | +90.5% | 3,734 | +22.7% | 0.00% | – |
| Q4 2017 | $21,000 | -22.2% | 3,042 | 0.0% | 0.00% | – |
| Q3 2017 | $27,000 | -3.6% | 3,042 | 0.0% | 0.00% | – |
| Q2 2017 | $28,000 | +366.7% | 3,042 | +293.5% | 0.00% | – |
| Q1 2017 | $6,000 | -14.3% | 773 | 0.0% | 0.00% | – |
| Q4 2016 | $7,000 | – | 773 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 2,458,600 | $5,630,000 | 5.96% |
| Carmignac Gestion | 2,485,652 | $5,692,000 | 0.09% |
| XTX Topco Ltd | 50,947 | $117,000 | 0.05% |
| Golden State Equity Partners | 31,327 | $72,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 78,274 | $179,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 316,600 | $725,000 | 0.01% |
| Newman Dignan & Sheerar, Inc. | 27,023 | $62,000 | 0.01% |
| Curi Wealth Management, LLC | 25,000 | $57,000 | 0.01% |
| Northeast Financial Consultants Inc | 53,000 | $121,000 | 0.01% |
| Assenagon Asset Management S.A. | 913,789 | $2,093,000 | 0.01% |